Ocimum basilicum in acne vulgaris--a controlled comparison with a standard regime
Balambal, R.; Thiruvengadam, K.V.; Kameswarant, L.; Janaki, V.R.; Thambiah, A.S.
Journal of the Association of Physicians of India 33(8): 507-508
1985
ISSN/ISBN: 0004-5772 PMID: 2932427 Document Number: 263670
Document emailed within 1 workday
Related Documents
Fernandez, R.; Griffiths, R. 2005: A comparison of an evidence based regime with the standard protocol for monitoring postoperative observation: a randomised controlled trial Australian Journal of Advanced Nursing: a Quarterly Publication of the Royal Australian Nursing Federation 23(1): 15-21Miele, M.; Ledda, B.; Falugi, C.; Mazzei, M. 2001: Methyleugenol and eugenol variation in Ocimum basilicum cv. Genovese gigante grown in greenhouse and in vitro Bollettino della Societa Italiana di Biologia Sperimentale 77(4-6): 43-50
Hiramatsu, H. 1970: Our standard "treatment of pimples" for acne vulgaris Hifuka Kiyo. Acta Dermatologica 65(3): 221-224
Bourne, M.S. 1979: Comparison of two lotions for acne vulgaris Practitioner 223(1334): 274-276
Wokalek, H. 1989: Open, controlled multicenter trial of 2 benzoyl peroxide preparations in the treatment of acne vulgaris Zeitschrift für Hautkrankheiten 64(2): 140-144
Santos-Caetano, J.ão.P..; Cargill, M.R.. 2019: A Randomized Controlled Tolerability Study to Evaluate Reformulated Benzoyl Peroxide Face Washes for Acne Vulgaris Journal of Drugs in Dermatology: Jdd 18(4): 350-356
Thiboutot, D.; Gold, M.H.; Jarratt, M.T.; Kang, S.; Kaplan, D.L.; Millikan, L.; Wolfe, J.; Loesche, C.; Baker, M. 2001: Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris Cutis 68(4 Suppl): 10-19
Eichenfield, L.F.; Jarratt, M.; Schlessinger, J.; Kempers, S.; Manna, V.; Hwa, J.; Liu, Y.; Graeber, M.; Albrecht, L.; Arthur, E.; Barba, A.; Barber, K.; Bond, M.; Bucko, A.; Clark, S.; Cornelison, R.; Dinehart, S.; Dinulos, J.; Draelos, Z.; Fisher, G.; Glazer, S.; Glenn, M.; Del Rey, M.; Haber, R.; Hamzavi, I.; Harris, H.; Jarratt, M.; Landells, I.; Lee, M.; Leonardi, C.; Loebl, A.; Lynde, C.; Matheson, R.; Moore, A.; Mraz, S.; Papp, K.; Pariser, D.; Rafal, E.; Smith, S.; Stough, D.; Swinehart, J.; Toole, J.; Tyring, S.; Vender, R.; Wasel, N.; Westmoreland, P.; Wiltz, H.; Wilson, D.; Bruce, S.; Carey, W.; Cook-Bolden, F.; Davidson, L.; Eichenfield, L.; Fahrner, L.; Fowler, J.; Gillum, P.; Gold, M.; Greenstein, D.; Heller, G.; Horowitz, D.; 2010: Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies Journal of Drugs in Dermatology: Jdd 9(6): 639-646
Feldman, S.R.; Werner, C.P.; Alió Saenz, A.B. 2013: The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies Journal of Drugs in Dermatology: Jdd 12(4): 438-446
Dhawan, S.S. 2009: Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris Cutis 83(5): 265-272
Kamal, M.; Polat, M. 2015: Effect of different doses of isotretinoin treatment on the levels of serum homocysteine, vitamin B 12 and folic acid in patients with acne vulgaris: a prospective controlled study JPMA. Journal of the Pakistan Medical Association 65(9): 950-953
Eichenfield, L.F.; Lain, T.; Frankel, E.H.; Jones, T.M.; Chang-Lin, J.-E.; Berk, D.R.; Ruan, S.; Kaoukhov, A. 2016: Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults with Acne Vulgaris: Second of two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled Trials Journal of Drugs in Dermatology: Jdd 15(8): 962-969
Tanghetti, E.; Dhawan, S.; Green, L.; Del Rosso, J.; Draelos, Z.; Leyden, J.; Shalita, A.; Glaser, D.A.; Grimes, P.; Webster, G.; Barnett, P.; Le Gall, N. 2010: Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris Journal of Drugs in Dermatology: Jdd 9(5): 549-558
Stoughton, R.B.; Cornell, R.C.; Gange, R.W.; Walter, J.F. 1980: Double-blind comparison of topical 1 percent clindamycin phosphate (Cleocin T) and oral tetracycline 500 mg/day in the treatment of acne vulgaris Cutis 26(4): 424-425; 429
Mazurkiewicz, W.; Kostanecki, W.; Blaszczyk, M.; Dabrowska, H. 1974: Treatment of some diseases involving keratinization such as acne vulgaris and acne phlegmonosa with vitamin a acid Przeglad Dermatologiczny 61(1): 61-64
Webster, G.F.; Guenther, L.; Poulin, Y.P.; Solomon, B.A.; Loven, K.; Lee, J. 2002: A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris Cutis 69(2 Suppl): 4-11
Eichenfield, L.F.; Alió Sáenz, A.B. 2011: Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study Journal of Drugs in Dermatology: Jdd 10(12): 1382-1396
Gold, M.H.; Rao, J.; Goldman, M.P.; Bridges, T.M.; Bradshaw, V.L.; Boring, M.M.; Guider, A.N. 2005: A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution Journal of Drugs in Dermatology: Jdd 4(1): 64-70
Tanghetti, E.; Dhawan, S.; Green, L.; Ling, M.; Downie, J.; Germain, M.A.; Kasteler, J.S.; Kircik, L.; Oefelein, M.G.; Draelos, Z. 2011: Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris Journal of Drugs in Dermatology: Jdd 10(7): 783-792
Kircik, L.H.; Dahl, A.; Yatskayer, M.; Raab, S.; Oresajo, C. 2012: Safety and efficacy of two anti-acne/anti-aging treatments in subjects with photodamaged skin and mild to moderate acne vulgaris Journal of Drugs in Dermatology: Jdd 11(6): 737-740